IL144126A0 - A method of altering the specificity of cyclooxygenase-inhibiting compounds - Google Patents

A method of altering the specificity of cyclooxygenase-inhibiting compounds

Info

Publication number
IL144126A0
IL144126A0 IL14412699A IL14412699A IL144126A0 IL 144126 A0 IL144126 A0 IL 144126A0 IL 14412699 A IL14412699 A IL 14412699A IL 14412699 A IL14412699 A IL 14412699A IL 144126 A0 IL144126 A0 IL 144126A0
Authority
IL
Israel
Prior art keywords
cyclooxygenase
altering
specificity
inhibiting compounds
compounds
Prior art date
Application number
IL14412699A
Other languages
English (en)
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of IL144126A0 publication Critical patent/IL144126A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14412699A 1999-01-07 1999-12-16 A method of altering the specificity of cyclooxygenase-inhibiting compounds IL144126A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11509099P 1999-01-07 1999-01-07
PCT/US1999/030219 WO2000040087A1 (en) 1999-01-07 1999-12-16 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors

Publications (1)

Publication Number Publication Date
IL144126A0 true IL144126A0 (en) 2002-05-23

Family

ID=22359275

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14412699A IL144126A0 (en) 1999-01-07 1999-12-16 A method of altering the specificity of cyclooxygenase-inhibiting compounds

Country Status (11)

Country Link
EP (1) EP1148783B1 (de)
JP (1) JP2002534361A (de)
CN (1) CN1227008C (de)
AT (1) ATE328593T1 (de)
AU (1) AU772705B2 (de)
BR (1) BR9917001A (de)
CA (1) CA2358241A1 (de)
DE (1) DE69931814T2 (de)
ES (1) ES2270634T3 (de)
IL (1) IL144126A0 (de)
WO (1) WO2000040087A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030346A1 (es) 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico
AU2002247284A1 (en) 2001-04-02 2002-10-15 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
FR2835433B1 (fr) * 2002-02-01 2006-02-17 Richard Lab M Utilisation de la 1-(-4-chlorobenzoyl)-5methoxy-2-methyl-1h- indole-3acetic 4-(acetylamino)phenylester pour la fabrication d'un medicament destine a inhiber exclusivement la cox2
EP1534305B9 (de) 2003-05-07 2007-03-07 Osteologix A/S Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
JP2007527397A (ja) * 2003-07-01 2007-09-27 マイクロバイア インコーポレイテッド Ｃｏｘ−２及びｆａａｈ阻害剤
JP2007534702A (ja) 2004-04-26 2007-11-29 バンダービルト・ユニバーシティ 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体
CN101528222A (zh) 2006-06-19 2009-09-09 范德比尔特大学 用于诊断性和治疗性靶向cox-2的方法和组合物
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285908A (en) * 1963-04-30 1966-11-15 Merck & Co Inc Indolyl acid amides
US3336194A (en) * 1963-04-30 1967-08-15 Merck & Co Inc Indolyl acid amides
FR2358145A1 (fr) 1976-03-29 1978-02-10 Richard Sa Laboratoire M Nouveau medicament anti-inflammatoire, analgesique et antipyretique a base de (p-chlorobenzoyl-1 methyl-2 methoxy-5)-indole-3 acetate de p-acetamidophenol
JPS5872560A (ja) * 1981-10-27 1983-04-30 Teikoku Chem Ind Corp Ltd インドメタシンフエニルエステル誘導体
JPS60152462A (ja) * 1984-01-20 1985-08-10 Terumo Corp インド−ル酢酸アミド誘導体の製造方法
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs

Also Published As

Publication number Publication date
DE69931814D1 (de) 2006-07-20
EP1148783A4 (de) 2003-05-21
AU2369700A (en) 2000-07-24
EP1148783A1 (de) 2001-10-31
ATE328593T1 (de) 2006-06-15
AU772705B2 (en) 2004-05-06
DE69931814T2 (de) 2007-01-04
CN1337851A (zh) 2002-02-27
JP2002534361A (ja) 2002-10-15
EP1148783B1 (de) 2006-06-07
CA2358241A1 (en) 2000-07-13
WO2000040087A1 (en) 2000-07-13
BR9917001A (pt) 2001-11-13
CN1227008C (zh) 2005-11-16
ES2270634T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
GB9722520D0 (en) Compounds
MXPA02009706A (es) Metodo para sintesis de perindopril y sus sales farmaceuticamente aceptables.
MXPA02011977A (es) Herbicidas de piridina sustituidas.
PL361355A1 (en) Phenylglycine derivatives
ZA200001882B (en) Process for inhibiting the polymerization of easily-polymerizable compounds.
YU5503A (sh) Nesteroidni supresori zapaljenja
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
BG106585A (en) Kinase inhibitors as therapeutic agents
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
MXPA01013406A (es) Compuestos inhibidores de vla-4.
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
WO2001014331A3 (en) Non-quinoline inhibitors of malaria parasites
IL144234A0 (en) Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
BG104447A (en) Biphenylamidine derivatives
IL144126A0 (en) A method of altering the specificity of cyclooxygenase-inhibiting compounds
MY128164A (en) Compounds
AU9093901A (en) Creatine ester pronutrient compounds and formulations
AU2956302A (en) A process for the preparation of taxan derivatives
MY125674A (en) Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
AP2001002045A0 (en) FKBP inhibitors.
ID21520A (id) Proses untuk produksi fermentatif cephalosporin terdeasilasi
IL156331A0 (en) A process for the preparation of paclitaxel
AU2001260419A1 (en) Use of n,n'-dibenzyl ethylene diamine n,n'-diacetic acid derivatives as anti-pollution agent

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees